Alterity Therapeutics (ATHE) Depreciation and Depletion (2015 - 2025)

Alterity Therapeutics' Depreciation and Depletion history runs 11 years deep, the most recent figure standing at $1395.2 for Q4 2025.

• In Q4 2025, Depreciation and Depletion fell 87.35% year-over-year to $1395.2; the TTM figure through Dec 2025 stood at $37296.1 (down 8.39% YoY), while the FY2025 annual figure was $18128.7, down 22.17% from the prior year.
• Depreciation and Depletion was $1395.2 for Q4 2025 at Alterity Therapeutics, down from $11027.0 in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $12924.9 in Q4 2022 to a low of $1395.2 in Q4 2025.
• Historically, Depreciation and Depletion has averaged $8421.1 across 5 years, with a median of $11027.0 in 2024.
• The sharpest annual moves came in 2022 and 2025: Depreciation and Depletion soared 168.73% in 2022, then plunged 87.35% in 2025.
• A 5-year view of Depreciation and Depletion shows it stood at $4809.6 in 2021, then jumped by 168.73% to $12924.9 in 2022, then fell by 7.55% to $11948.9 in 2023, then retreated by 7.72% to $11027.0 in 2024, then slumped by 87.35% to $1395.2 in 2025.
• The last three Depreciation and Depletion figures came in at $1395.2 (Q4 2025), $11027.0 (Q4 2024), and $11948.9 (Q4 2023), per Business Quant data.